RT Journal Article
SR Electronic
T1 C-reactive protein as a triage tool for adults with presumptive pulmonary tuberculosis in South Africa: a prospective cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.12.21264791
DO 10.1101/2021.10.12.21264791
A1 Claire J Calderwood
A1 Byron WP Reeve
A1 Tiffeney Mann
A1 Zaida Palmer
A1 Georgina Nyawo
A1 Hridesh Mishra
A1 Ibrahim Abubakar
A1 Mahdad Noursadeghi
A1 Grant Theron
A1 Rishi K Gupta
YR 2021
UL http://medrxiv.org/content/early/2021/10/16/2021.10.12.21264791.abstract
AB Background Identification of an accurate, low-cost triage test for pulmonary TB among people presenting to healthcare facilities is an urgent global research priority. We assessed the diagnostic accuracy and clinical utility of C-reactive protein (CRP) for TB triage among symptomatic adult outpatients, irrespective of HIV status.Methods We prospectively enrolled adults reporting at least one (for people with HIV) or two (for people without HIV) symptoms of cough, fever, night sweats, or weight loss at two TB clinics in Cape Town, South Africa. Participants provided sputum for culture and Xpert MTB/RIF Ultra. We evaluated the diagnostic accuracy of CRP (measured using a laboratory-based assay) against a TB-culture reference standard as the area under the receiver operating characteristic curve (AUROC) and sensitivity and specificity at pre-specified thresholds. We assessed clinical utility using decision curve analysis, benchmarked against WHO recommendations.Results Of 932 included individuals, 255 (27%) had culture-confirmed TB and 389 (42%) were living with HIV. CRP demonstrated an AUROC of 0.80 (95% confidence interval 0.77–0.83), with sensitivity 93% (89–95%) and specificity 54% (50–58%) using a primary cut-off of ≥10mg/L. Performance was similar among people with HIV to those without. In decision curve analysis, CRP-based triage offered greater clinical utility than confirmatory testing for all up to a number willing to test threshold of 20 confirmatory tests per true positive TB case diagnosed.Conclusions CRP approached the WHO-defined minimum performance for a TB triage test and showed evidence of clinical utility among symptomatic outpatients, irrespective of HIV status.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGT acknowledges funding for this study from South African Medical Research Council (SAMRC Flagship Project MRC-RFA-IFSP-01-2013), the EDCTP2 program supported by the European Union (grant SF1401, OPTIMAL DIAGNOSIS), the Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, and a Royal Society Newton Advanced fellowship (NA-150-202). BWPR and HM acknowledge funding from the Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. MN is funded by the Wellcome Trust (207511/Z/17/Z), and by National Institute of Health Research (NIHR) Biomedical Research Funding to UCL and UCLH. CJC, IA and RKG report funding from the NIHR (DRF-2018-11-ST2-004 to RKG; NF-SI-0616-10037 to IA). Additionally, Cepheid gave in-kind cartridges and equipment donations to the clinical study (BAR-TB) from which the specimens in this manuscript were derived. This paper presents independent research supported by the NIHR. The views expressed are those of the author(s) and not necessarily those of the UK National Health Service, the NIHR or the UK Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the Stellenbosch University Faculty of Health Sciences Research gave ethical approval for this work (N14/10/136).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe de-identified patient data, study protocol, informed consent form, and datasets generated and/or analysed are available from BWPR and CJC on reasonable request.